European Ultrahigh-Field Imaging Network for Neurodegenerative Diseases (EUFIND)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Emrah D€uzel | - |
dc.contributor.author | Julio Acosta-Cabronero | - |
dc.contributor.author | David Berron | - |
dc.contributor.author | Geert Jan Biessels | - |
dc.contributor.author | Isabella Bj€orkman-Burtscher | - |
dc.contributor.author | Michel Bottlaender | - |
dc.contributor.author | Richard Bowtell | - |
dc.contributor.author | Mark v Buchem | - |
dc.contributor.author | Arturo Cardenas-Blanco | - |
dc.contributor.author | Fawzi Boumezbeur | - |
dc.contributor.author | Dennis Chan | - |
dc.contributor.author | Mauro Costagli | - |
dc.contributor.author | Ludovic de Rochefort | - |
dc.contributor.author | Ariane Fillmer | - |
dc.contributor.author | Penny Gowland | - |
dc.contributor.author | Oskar Hansson | - |
dc.contributor.author | Jeroen Hendrikse | - |
dc.contributor.author | Oliver Kraff | - |
dc.contributor.author | Mark E. Ladd | - |
dc.contributor.author | Itamar Ronen | - |
dc.contributor.author | Esben Petersen | - |
dc.contributor.author | James B. Rowe | - |
dc.contributor.author | Hartwig Siebner | - |
dc.contributor.author | Tony Stoecker | - |
dc.contributor.author | Sina Straub | - |
dc.contributor.author | Michela Tosetti | - |
dc.contributor.author | Kamil Uludag | - |
dc.contributor.author | Alexandre Vignaud | - |
dc.contributor.author | Jaco Zwanenburg | - |
dc.contributor.author | Oliver Speck | - |
dc.date.available | 2019-10-11T08:06:00Z | - |
dc.date.created | 2019-08-20 | - |
dc.date.issued | 2019-12 | - |
dc.identifier.issn | 2352-8729 | - |
dc.identifier.uri | https://pr.ibs.re.kr/handle/8788114/6258 | - |
dc.description.abstract | © 2018 The AuthorsIntroduction: The goal of European Ultrahigh-Field Imaging Network in Neurodegenerative Diseases (EUFIND) is to identify opportunities and challenges of 7 Tesla (7T) MRI for clinical and research applications in neurodegeneration. EUFIND comprises 22 European and one US site, including over 50 MRI and dementia experts as well as neuroscientists. Methods: EUFIND combined consensus workshops and data sharing for multisite analysis, focusing on 7 core topics: clinical applications/clinical research, highest resolution anatomy, functional imaging, vascular systems/vascular pathology, iron mapping and neuropathology detection, spectroscopy, and quality assurance. Across these topics, EUFIND considered standard operating procedures, safety, and multivendor harmonization. Results: The clinical and research opportunities and challenges of 7T MRI in each subtopic are set out as a roadmap. Specific MRI sequences for each subtopic were implemented in a pilot study presented in this report. Results show that a large multisite 7T imaging network with highly advanced and harmonized imaging sequences is feasible and may enable future multicentre ultrahigh-field MRI studies and clinical trials. Discussion: The EUFIND network can be a major driver for advancing clinical neuroimaging research using 7T and for identifying use-cases for clinical applications in neurodegeneration | - |
dc.description.uri | 1 | - |
dc.language | 영어 | - |
dc.publisher | Elsevier Inc. | - |
dc.subject | Alzheimer&apos | - |
dc.subject | s disease (AD) | - |
dc.subject | Magnetic resonance imaging (MRI) | - |
dc.subject | Mild cognitive impairment (MCI) | - |
dc.subject | Parkinson&apos | - |
dc.subject | s disease (PD) | - |
dc.subject | Subjective cognitive decline (SCD) | - |
dc.subject | Ultrahigh-field MRI | - |
dc.subject | Vascular dementia | - |
dc.title | European Ultrahigh-Field Imaging Network for Neurodegenerative Diseases (EUFIND) | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.identifier.scopusid | 2-s2.0-85069944986 | - |
dc.identifier.rimsid | 69387 | - |
dc.contributor.affiliatedAuthor | Kamil Uludag | - |
dc.identifier.doi | 10.1016/j.dadm.2019.04.010 | - |
dc.identifier.bibliographicCitation | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, v.11, pp.538 - 549 | - |
dc.citation.title | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | - |
dc.citation.volume | 11 | - |
dc.citation.startPage | 538 | - |
dc.citation.endPage | 549 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordAuthor | Alzheimer&apos | - |
dc.subject.keywordAuthor | s disease (AD) | - |
dc.subject.keywordAuthor | Magnetic resonance imaging (MRI) | - |
dc.subject.keywordAuthor | Mild cognitive impairment (MCI) | - |
dc.subject.keywordAuthor | Parkinson&apos | - |
dc.subject.keywordAuthor | s disease (PD) | - |
dc.subject.keywordAuthor | Subjective cognitive decline (SCD) | - |
dc.subject.keywordAuthor | Ultrahigh-field MRI | - |
dc.subject.keywordAuthor | Vascular dementia | - |